In this study, three commercial systems for the preparation of platelet-rich plasma (PRP) were compared and platelet growth factors release was measured.
Aim of this study was to assess the prevalence, clinical meaning and modifications of mitral regurgitation (MR) in patients undergoing transcatheter aortic valve implantation (TAVI).
